Author

D. Kaufman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1 Paleontology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:cell signaling & trafficking· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Rogich· 1 shared B. Dillion· 1 shared B. Walcheck· 1 shared C. P. Clark· 1 shared D. Mendez· 1 shared G. P. Dietl· 1 shared H. Mishra· 1 shared J. C. Handley· 1 shared

Activity by Year

2018-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Rogich

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Age variability and time averaging in oyster reef death assemblages

S. R. Durham, G. P. Dietl, Q. Hua, J. C. Handley, D. Kaufman, C. P. Clark

This study examines age variability and time averaging in oyster reef death assemblages, finding that shallow reef DAs have high temporal resolution, useful for habitat management.

bioRxiv · Nov 5, 2022 · PreprintPaleontology

GABA-receptors are a new druggable target for limiting disease severity, lung viral load, and death in SARS-CoV-2 infected mice

J. Tian, B. Dillion, J. Henley, L. Comai, D. Kaufman

This study shows that GABA-receptor agonists reduce disease severity, lung viral load, and death in SARS-CoV-2 infected mice.

bioRxiv · Jun 7, 2022Microbiology

Expression of a recombinant high affinity IgG Fc receptor by engineered NK cells as a docking platform for therapeutic mAbs to target cancer cells

K. Snyder, R. Hullsiek, H. Mishra, D. Mendez, Y. Li, A. Rogich, D. Kaufman, J. Wu, B. Walcheck

This paper engineers NK cells with a recombinant Fc receptor to enhance ADCC and tumor targeting by avoiding ADAM17-mediated downregulation.

bioRxiv · Oct 2, 2018Immunology